These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 28658052

  • 1. Assessment of nodal involvement in non-small-cell lung cancer with 18F-FDG-PET/CT: mediastinal blood pool cut-off has the highest sensitivity and tumour SUVmax/2 has the highest specificity.
    Mallorie A, Goldring J, Patel A, Lim E, Wagner T.
    Nucl Med Commun; 2017 Aug; 38(8):715-719. PubMed ID: 28658052
    [Abstract] [Full Text] [Related]

  • 2. Improving diagnostic performance of 18F-FDG-PET/CT for assessment of regional nodal involvement in non-small cell lung cancer.
    Yang DD, Mirvis E, Goldring J, Patel ARC, Wagner T.
    Clin Radiol; 2019 Oct; 74(10):818.e17-818.e23. PubMed ID: 31420186
    [Abstract] [Full Text] [Related]

  • 3. Is FDG-PET/CT used correctly in the combined approach for nodal staging in NSCLC patients?
    Simsek FS, Comak A, Asik M, Kuslu D, Balci TA, Ulutas H, Koroglu R, Kekilli E, Akatli A, Elmali F, Yalcin NC, Akyol H.
    Niger J Clin Pract; 2020 Jun; 23(6):842-847. PubMed ID: 32525121
    [Abstract] [Full Text] [Related]

  • 4. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.
    Miyasaka Y, Suzuki K, Takamochi K, Matsunaga T, Oh S.
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):83-7. PubMed ID: 23233074
    [Abstract] [Full Text] [Related]

  • 5. Association of maximum standardized uptake value with occult mediastinal lymph node metastases in cN0 non-small cell lung cancer.
    Lin JT, Yang XN, Zhong WZ, Liao RQ, Dong S, Nie Q, Weng SX, Fang XJ, Zheng JY, Wu YL.
    Eur J Cardiothorac Surg; 2016 Nov; 50(5):914-919. PubMed ID: 27113090
    [Abstract] [Full Text] [Related]

  • 6. Impact of 18F-FDG PET/CT, CT and EBUS/TBNA on preoperative mediastinal nodal staging of NSCLC.
    Al-Ibraheem A, Hirmas N, Fanti S, Paez D, Abuhijla F, Al-Rimawi D, Al-Rasheed U, Abdeljalil R, Hawari F, Alrabi K, Mansour A.
    BMC Med Imaging; 2021 Mar 17; 21(1):49. PubMed ID: 33731050
    [Abstract] [Full Text] [Related]

  • 7. PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer.
    Schmidt-Hansen M, Baldwin DR, Hasler E, Zamora J, Abraira V, Roqué I Figuls M.
    Cochrane Database Syst Rev; 2014 Nov 13; 2014(11):CD009519. PubMed ID: 25393718
    [Abstract] [Full Text] [Related]

  • 8. The diagnostic ability of 18F-FDG PET/CT for mediastinal lymph node staging using 18F-FDG uptake and volumetric CT histogram analysis in non-small cell lung cancer.
    Lee JW, Kim EY, Kim DJ, Lee JH, Kang WJ, Lee JD, Yun M.
    Eur Radiol; 2016 Dec 13; 26(12):4515-4523. PubMed ID: 26943133
    [Abstract] [Full Text] [Related]

  • 9. Endobronchial ultrasound-guided transbronchial needle aspiration of hilar and mediastinal lymph nodes detected on 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
    Minami D, Takigawa N, Oda N, Ninomiya T, Kubo T, Ohashi K, Sato A, Hotta K, Tabata M, Kaji M, Tanimoto M, Kiura K.
    Jpn J Clin Oncol; 2016 Jun 13; 46(6):529-33. PubMed ID: 27004902
    [Abstract] [Full Text] [Related]

  • 10. Clinical Predictors of Nodal Metastases in Peripherally Clinical T1a N0 Non-Small Cell Lung Cancer.
    Ghaly G, Rahouma M, Kamel MK, Nasar A, Harrison S, Nguyen AB, Port J, Stiles BM, Altorki NK, Lee PC.
    Ann Thorac Surg; 2017 Oct 13; 104(4):1153-1158. PubMed ID: 28551047
    [Abstract] [Full Text] [Related]

  • 11. FDG-PET parameters predicting mediastinal malignancy in lung cancer.
    Serra Fortuny M, Gallego M, Berna L, Montón C, Vigil L, Masdeu MJ, Fernández-Villar A, Botana MI, Cordovilla R, García-Luján R, Cases E, Monsó E.
    BMC Pulm Med; 2016 Dec 08; 16(1):177. PubMed ID: 27931198
    [Abstract] [Full Text] [Related]

  • 12. Ratio between maximum standardized uptake value of N1 lymph nodes and tumor predicts N2 disease in patients with non-small cell lung cancer in 18F-FDG PET-CT scan.
    Honguero Martínez AF, García Jiménez MD, García Vicente A, López-Torres Hidalgo J, Colon MJ, van Gómez López O, Soriano Castrejón ÁM, León Atance P.
    Rev Esp Med Nucl Imagen Mol; 2016 Dec 08; 35(3):159-64. PubMed ID: 26514322
    [Abstract] [Full Text] [Related]

  • 13. Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients.
    Kim YK, Lee KS, Kim BT, Choi JY, Kim H, Kwon OJ, Shim YM, Yi CA, Kim HY, Chung MJ.
    Cancer; 2007 Mar 15; 109(6):1068-77. PubMed ID: 17311309
    [Abstract] [Full Text] [Related]

  • 14. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
    Billé A, Pelosi E, Skanjeti A, Arena V, Errico L, Borasio P, Mancini M, Ardissone F.
    Eur J Cardiothorac Surg; 2009 Sep 15; 36(3):440-5. PubMed ID: 19464906
    [Abstract] [Full Text] [Related]

  • 15. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
    Turkmen C, Sonmezoglu K, Toker A, Yilmazbayhan D, Dilege S, Halac M, Erelel M, Ece T, Mudun A.
    Clin Nucl Med; 2007 Aug 15; 32(8):607-12. PubMed ID: 17667432
    [Abstract] [Full Text] [Related]

  • 16. Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer.
    Li X, Zhang H, Xing L, Xu X, Xie P, Ma H, Zhang L, Chen M, Sun X, Xu W, Chen L, Yu J.
    Clin Lung Cancer; 2013 Sep 15; 14(5):568-73. PubMed ID: 23835164
    [Abstract] [Full Text] [Related]

  • 17. Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non-small cell lung carcinoma?
    Sivrikoz CM, Ak I, Simsek FS, Döner E, Dündar E.
    Thorac Cardiovasc Surg; 2012 Mar 15; 60(2):116-21. PubMed ID: 21692019
    [Abstract] [Full Text] [Related]

  • 18. Combination of Fluorine-18 Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography (¹⁸F-FDG PET/CT) and Tumor Markers to Diagnose Lymph Node Metastasis in Non-Small Cell Lung Cancer (NSCLC): A Retrospective and Prospective Study.
    Zhai X, Guo Y, Qian X.
    Med Sci Monit; 2020 Jun 02; 26():e922675. PubMed ID: 32483109
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.